The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...
Consult virtually and on-demand with a healthcare professional about their test result; Obtain an e-prescription - if medically indicated - for a medication to treat the virus; and Get the medication ...
The FDA granted emergency use authorization June 12 to healthcare tech company Cue Heath’s rapid COVID-19 test. The single-use molecular test identifies the RNA of the virus that causes COVID-19 from ...
Oct 13 (Reuters) - The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and ...
SAN DIEGO, Oct. 6, 2022 /PRNewswire/ -- Cue Health Inc. (HLTH), a healthcare technology company, has partnered with actress Jamie-Lynn Sigler, the actress best known for her roles on The Sopranos and ...
Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID-19 test, dubbed the Cue COVID-19 Molecular Test. The Cue COVID-19 Molecular Test detects ...
If so inclined, an NBA player could now test himself for the coronavirus and get results on his phone in no more than 20 minutes. And the league is convinced those tests are both fast enough and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results